The United States Swine Vaccine Industry is also expected to experience healthy growth, with a projected valuation of US$319 million by 2032. This represents a CAGR of 6%, indicating a steady rise in demand for swine vaccines within the US market. The absolute dollar potential for the US market is estimated at US$137 million, highlighting …